MX9600642A - Sal de nimesulida soluble en agua y su preparacion, solucion acuosa que la contiene, combinaciones a base de nimesulida y sus usos. - Google Patents

Sal de nimesulida soluble en agua y su preparacion, solucion acuosa que la contiene, combinaciones a base de nimesulida y sus usos.

Info

Publication number
MX9600642A
MX9600642A MX9600642A MX9600642A MX9600642A MX 9600642 A MX9600642 A MX 9600642A MX 9600642 A MX9600642 A MX 9600642A MX 9600642 A MX9600642 A MX 9600642A MX 9600642 A MX9600642 A MX 9600642A
Authority
MX
Mexico
Prior art keywords
water
inflammations
treatment
soluble
nimesulide salt
Prior art date
Application number
MX9600642A
Other languages
English (en)
Other versions
MXPA96000642A (es
Inventor
Bernard Pirotte
Geraldine Piel
Philippe Neven
Isabelle Delneuville
Joszef Geczy
Original Assignee
Europharmaceuticals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Europharmaceuticals Sa filed Critical Europharmaceuticals Sa
Publication of MX9600642A publication Critical patent/MX9600642A/es
Publication of MXPA96000642A publication Critical patent/MXPA96000642A/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)

Abstract

La sal de nimesulida soluble en agua que consiste del producto de reaccion de la nimesulida y de la L-lisina y su preparacion, la solucion acuosa que la contiene, las combinaciones a base de nimesulida con ciclodextrinas y sus usos.
MXPA/A/1996/000642A 1994-06-16 1996-02-16 Sal de nimesulida soluble en agua y su preparacion, solucion acuosa que la contiene, combinaciones a base de nimesulida y sus usos MXPA96000642A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BE9400582A BE1008307A3 (fr) 1994-06-16 1994-06-16 Sel de nimesulide hydrosoluble, solution aqueuse le contenant, sa preparation et son utilisation.
BE9400582 1994-06-16
PCT/BE1995/000055 WO1995034533A1 (fr) 1994-06-16 1995-06-16 Sel de nimesulide hydrosoluble et leurs utilisations pour le traitement des affections inflammatoires

Publications (2)

Publication Number Publication Date
MX9600642A true MX9600642A (es) 1997-07-31
MXPA96000642A MXPA96000642A (es) 1997-12-01

Family

ID=

Also Published As

Publication number Publication date
EP0714386A1 (fr) 1996-06-05
AU2708595A (en) 1996-01-05
HUT76475A (en) 1997-09-29
WO1995034533A1 (fr) 1995-12-21
SK35696A3 (en) 1996-12-04
PL313031A1 (en) 1996-05-27
CA2169747A1 (fr) 1995-12-21
GR3030437T3 (en) 1999-09-30
DK0714386T3 (da) 1999-09-27
JPH09503002A (ja) 1997-03-25
BE1008307A3 (fr) 1996-04-02
CZ79296A3 (en) 1996-10-16
CZ289746B6 (cs) 2002-03-13
RU2151764C1 (ru) 2000-06-27
DE69508192D1 (de) 1999-04-15
DE69508192T2 (de) 1999-10-14
HU9600654D0 (en) 1996-05-28
NZ288150A (en) 1998-09-24
AU693901B2 (en) 1998-07-09
UA42734C2 (uk) 2001-11-15
PL179789B1 (pl) 2000-10-31
SK281496B6 (sk) 2001-04-09
ATE177421T1 (de) 1999-03-15
EP0714386B1 (fr) 1999-03-10
ES2132678T3 (es) 1999-08-16
US5756546A (en) 1998-05-26

Similar Documents

Publication Publication Date Title
AU2708595A (en) Water-soluble nimesulide salt, and uses thereof for the treatment of inflammations
CA2381770A1 (en) Human ctla-4 antibodies and their uses
WO2000034265A3 (en) Quinoline-indole antimicrobial agents
NO307336B1 (no) 2-[(Dihydro)pyrazolyl-3'-oksylmetylen]anilider, anvendelse derav, samt middel inneholdende forbindelsen og mellomprodukter for fremstilling av forbindelsen
EP0955044A3 (en) Method of inhibiting bacterial or fungal growth using a complexing agent
CA2209060A1 (en) Water-soluble or water-swellable polymers
AU5485698A (en) Oxyiminopregnancarbolactone
IS4338A (is) Arabínosýlansundrandi ensím
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
ES2176456T3 (es) Procedimiento de preparacion de un compuesto inhibidor del vih proteasa.
AU5638200A (en) Tissue products having antiviral properties
ES2026314A6 (es) Procedimiento para obtener una composicion profilactica antimicrobiana oftalmica neonatal.
WO1999067238A3 (en) Tetrahydroquinoline-indole derivatives antimicrobial agents, their uses and compositions containing them
AU2001260077A1 (en) Microfiltration using activated carbon
AU1894295A (en) 2-cyano-1,3-dione derivatives useful as herbicides
AU8445791A (en) Use of pyridylmethylsulphinyl-1h-benzimidazole derivates in the treatment of illnesses caused by helicobacter bacteria
EP0383361A3 (en) 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide for use in medical treatment of humans
MX9700624A (es) Azolidinonas de imidazopiridina.
ATE188114T1 (de) Milde, wässrige, tensidische zubereitungen für kosmetische zwecke und reinigungsmittel
AU5419699A (en) Methoximinophenylacetic acid amides
EP1018336A4 (en) carcinostatic
AU7126996A (en) Aqueous solutions of formic acid, propionic acid and ammonia and the use thereof
AU3406089A (en) Novel strobilurine derivatives, their preparation and their use
BG104452A (en) New derivatives of the methylenebisphosphonic acid
AU6290398A (en) Inclusion complexes in aqueous solution